State Medicaid Drug Utilization Data for 2016

State-reported data tracks Medicaid spending on outpatient drugs, including drug names, National Drug Codes, prescription counts, and reimbursement dollars. The U.S. Department of Health & Human Services provides this data for the 2016 calendar year. It originates from the Medicaid Drug Rebate Program, which requires states to report utilization for covered outpatient drugs.

Use Cases

• Analyzing state-level prescription drug spending based on reported reimbursement dollars.
• Comparing utilization rates for specific drugs across states based on the number of prescriptions.
• Tracking pharmaceutical market share within Medicaid based on drug name and National Drug Code identifiers.
• Investigating geographic variations in drug access and cost based on state-level reporting.

Strengths

• Data is reported by state Medicaid agencies, providing an official administrative source.
• Includes key financial and volume metrics: dollars reimbursed and number of prescriptions.
• Covers the full 2016 calendar year for temporal analysis.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

U.S. Department of Health & Human Services

Collection Method

Reported by state Medicaid agencies for the Medicaid Drug Rebate Program.

Time Range

2016

Freshness

Last updated 2026-04-08 20:34:08.755282; freshness should be verified.

Geography

United States (state-level)